register

Marketing & Strategy

Reimagine the ‘new normal’ of HCP engagement

Health Industry Hub | November 30, 2020 |

Marketing & Strategy: The greatest danger in times of turbulence is not the turbulence, it is to act with yesterday’s logic. Peter Drucker

As a result of COVID-19, the traditional HCP customer engagement models are evolving into a ‘new normal’.

In a recent interview with Health Industry Hub, Ross Murray, Strategic Partnership Director at Australian Doctor Group (ADG), discussed the emerging trends in customer engagement, the future of face-to-face HCP interactions and the impact of digital marketing and personalised content delivery on brand management.

  1. What are the key emerging trends impacting clinicians and how does this influence pharma’s marketing and commercial engagement with HCPs?
  2. How can companies bridge the gap between f2f and virtual engagement to achieve a sustainable competitive advantage in the ‘new normal’?
  3. How are innovative brands leveraging data and analytics to understand where digital marketing is influencing HCP behaviour in order to complement field force activity and drive ROI?
  4. What are the key barriers to delivering and optimising content in an agile manner to meet clinician needs?
  5. How does digital unlock more value from pharma marketing investments?

News & Trends - MedTech & Diagnostics

Medtronic partners with local researchers in stroke trial

Medtronic partners with local researchers in stroke trial

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: Endovascular thrombectomy has been shown to be more effective in reducing disability than medical therapy alone […]

More


News & Trends - Pharmaceuticals

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Industry Hub | March 1, 2024 |

Pharma News: Mark Butler MP, Federal Minister for Health, and Senator Anne Ruston, Shadow Minister for Health, reflected on the […]

More


News & Trends - Pharmaceuticals

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Health Industry Hub | March 1, 2024 |

Pharma News: Gilead has applied to the Medical Services Advisory Committee (MSAC) for funding of its cutting-edge CAR T-cell therapy, […]

More


News & Trends - MedTech & Diagnostics

Should private insurers face scrutiny for soaring profits while patients foot the bill? MTAA, Private Healthcare Australia

Should private health insurers face scrutiny for soaring profits while patients foot the bill?

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: In a clash of interests, the Medical Technology Association of Australia (MTAA) has once again urged […]

More


This content is copyright protected. Please subscribe to gain access.